These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9813358)

  • 1. Depletion of dopamine in the nucleus accumbens prevents the generation of locomotion by metabotropic glutamate receptor activation.
    Meeker D; Kim JH; Vezina P
    Brain Res; 1998 Nov; 812(1-2):260-4. PubMed ID: 9813358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of metabotropic glutamate receptors in the rat nucleus accumbens increases locomotor activity in a dopamine-dependent manner.
    Kim JH; Vezina P
    J Pharmacol Exp Ther; 1997 Nov; 283(2):962-8. PubMed ID: 9353420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microinfusion of the metabotropic glutamate receptor agonist 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid into the nucleus accumbens induces dopamine-dependent locomotor activation in the rat.
    Attarian S; Amalric M
    Eur J Neurosci; 1997 Apr; 9(4):809-16. PubMed ID: 9153588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabotropic glutamate receptor antagonist (RS)-MCPG produces hyperlocomotion in amphetamine pre-exposed rats.
    Kim JH; Vezina P
    Neuropharmacology; 1998; 37(2):189-97. PubMed ID: 9680243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Previous exposure to amphetamine enhances the subsequent locomotor response to a D1 dopamine receptor agonist when glutamate reuptake is inhibited.
    Kim JH; Perugini M; Austin JD; Vezina P
    J Neurosci; 2001 Mar; 21(5):RC133. PubMed ID: 11222671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent increase in dopamine release following activation of metabotropic glutamate receptors in the rat nucleus accumbens.
    Ohno M; Watanabe S
    Neurosci Lett; 1995 Nov; 200(2):113-6. PubMed ID: 8614557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of group II, but not group I, mGluRs in the rat nucleus accumbens inhibits the expression of conditioned hyperactivity in an amphetamine-associated environment.
    Kim WY; Vezina P; Kim JH
    Behav Brain Res; 2008 Aug; 191(1):62-6. PubMed ID: 18433894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague-Dawley rats.
    Grauer SM; Marquis KL
    Psychopharmacology (Berl); 1999 Feb; 141(4):405-12. PubMed ID: 10090648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion.
    Kim JH; Vezina P
    J Pharmacol Exp Ther; 1998 Jan; 284(1):317-22. PubMed ID: 9435194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group II, but not group I, metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion.
    Kim JH; Beeler JA; Vezina P
    Neuropharmacology; 2000 Jul; 39(10):1692-9. PubMed ID: 10884551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locomotor sensitization is expressed by ghrelin and D1 dopamine receptor agonist in the nucleus accumbens core in amphetamine pre-exposed rat.
    Jang JK; Kim WY; Cho BR; Lee JW; Kim JH
    Addict Biol; 2018 May; 23(3):849-856. PubMed ID: 28635134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of group II metabotropic glutamate receptors in the nucleus accumbens produces hyperlocomotion in rats previously exposed to amphetamine.
    Chi H; Jang JK; Kim JH; Vezina P
    Neuropharmacology; 2006 Oct; 51(5):986-92. PubMed ID: 16901517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabotropic glutamate receptor agonist-induced hyperpolarizations in rat basolateral amygdala neurons: receptor characterization and ion channels.
    Holmes KH; Keele NB; Arvanov VL; Shinnick-Gallagher P
    J Neurophysiol; 1996 Nov; 76(5):3059-69. PubMed ID: 8930255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1S,3R-ACPD has cataleptogenic effects and reverses MK-801-, and less pronounced, D,L-amphetamine-induced locomotion.
    Kronthaler UO; Schmidt WJ
    Eur J Pharmacol; 1996 Dec; 316(2-3):129-36. PubMed ID: 8982678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of metabotropic glutamate receptors coupled to phospholipase D in the rat hippocampus.
    Pellegrini-Giampietro DE; Torregrossa SA; Moroni F
    Br J Pharmacol; 1996 Jun; 118(4):1035-43. PubMed ID: 8799579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabotropic glutamate receptors regulate N-methyl-D-aspartate-mediated synaptic transmission in nucleus accumbens.
    Martin G; Nie Z; Siggins GR
    J Neurophysiol; 1997 Dec; 78(6):3028-38. PubMed ID: 9405522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons.
    Meltzer LT; Serpa KA; Christoffersen CL
    Synapse; 1997 Jun; 26(2):184-93. PubMed ID: 9131777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of CaMKII in the nucleus accumbens shell decreases enhanced amphetamine intake in sensitized rats.
    Loweth JA; Baker LK; Guptaa T; Guillory AM; Vezina P
    Neurosci Lett; 2008 Oct; 444(2):157-60. PubMed ID: 18694805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compensatory increase in extracellular dopamine in the nucleus accumbens of adult rats with neonatal 6-hydroxydopamine treatment.
    Ikegami M; Ichitani Y; Takahashi T; Iwasaki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Jun; 26(3):111-7. PubMed ID: 16866211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.